HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

CID 790

HCID 790
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
68-94-0
Standard SMILES
O=c1nc[nH]c2nc[nH]c12
InChIKey
FDGQSTZJBFJUBT-UHFFFAOYSA-N
Molecular formula
C5H4N4O
Average molar mass
136.11 g/mol
Monoisotopic mass
136.03851076

Overview

Hypoxanthine is a purine and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway.

Names & identifiers

Preferred name
CID 790
IUPAC
3,7-dihydropurin-6-one
English name
6-Hydroxypurine
Molecular formula
C5H4N4O
Molecular weight
136.11

Names & synonyms

HYPOXANTHINE9H-PURIN-6-OLHypoxanthine,99%Hypoxanthine-d4Hypoxanthine, 99.5%3,7-dihydropurin-6-oneAzathioprine EP Impurity F1,7-DIHYDRO-6H-PURIN-6-ONE6H-Purin-6-one, 1,7-dihydro-6H-Purin-6-one, 1,9-dihydro-

Database identifiers

CAS
68-94-0
PubChem CID
790
DTXSID
DTXSID8045983

Properties

Computed structural properties

XLogP
-1.1
Topological polar surface area
70.1 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
2
Rotatable bonds
0
Heavy atoms
10
Formal charge
0
Complexity
190

Experimental & physicochemical properties

DrugsPharmaceutical
LogP-1.11
Solubility0.7 mg/mL
Melting Point150 °C
Physical DescriptionSolid
Collision Cross Section135.9 Ų [M+Na]+

Physicochemical properties

Melting point
300 °C · >300 °C (lit.)
Boiling point
250.36 °C · 250.36°C (rough estimate)
Density
1.4295 · 1.4295 (rough estimate)
refractive index
1.85 · 1.8500 (estimate)
storage temp.
2 · 2-8°C
solubility
1 M · 1 M NaOH: 25 mg/mL
form
powder

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Toxicology

Treatment · 1 item

Chronic Exposure: Kidney dialysis is usually needed to relieve the symptoms of xanthine toxicity until normal kidney function can be restored. Acute Exposure: EYES: irrigate opened eyes for several minutes under running water. INGESTION: do not induce vomiting. Rinse mouth with water (never give anything by mouth to an unconscious person). Seek immediate medical advice.

Health Effects · 1 item

As a uremic toxin, this compound can cause uremic syndrome. Uremic syndrome may affect any part of the body and can cause nausea, vomiting, loss of appetite, and weight loss. It can also cause changes in mental status, such as confusion, reduced awareness, agitation, psychosis, seizures, and coma. Abnormal bleeding, such as bleeding spontaneously or profusely from a very minor injury can also occur. Heart problems, such as an irregular heartbeat, inflammation in the sac that surrounds the heart (pericarditis), and increased pressure on the heart can be seen in patients with uremic syndrome. Shortness of breath from fluid buildup in the space between the lungs and the chest wall (pleural effusion) can also be present. Chronically high concentrations of hpyoxanthine can lead to health problems such as renal failure and xanthine kidney stones, one of the rarest types of kidney stones. Chronically high levels of hypoxanthine are associated with at least 4 inborn errors of metabolism including: Xanthinuria type I, Xanthuria type II, Molybdenium Cofactor Deficiency, and Xanthinuria.

Exposure RoutesEndogenous, Ingestion, Dermal (contact)
Toxicity SummaryHypoxanthine is a poorly soluble compound. As a result high concentrations of serum hypoxanthine can lead to the formation of kidney stones which can, over the long term, induce kidney failure.
Signs and SymptomsMay lead to arthropathy, myopathy, crystal nephropathy, urolithiasis, or renal failure.
Carcinogen Classification

Chemistry & industry

Pharmacology

Metabolism/Metabolites · 1 item

Under normal circumstances hypoxanthine is readily converted to uric acid. The enzyme xanthine oxidase makes uric acid from xanthine and hypoxanthine, which in turn are produced from other purines. In humans and higher primates, uric acid is the final oxidation (breakdown) product of purine metabolism and is excreted in urine.

Tissue LocationsAdipose Tissue
Cellular LocationsCytoplasm
Metabolite PathwaysAdenine phosphoribosyltransferase deficiency (APRT)

Uses & manufacturing

UsesNaturally produced by the body (endogenous).
Applications · 5 items

DescriptionHypoxanthine is a naturally occurring purine derivative and intermediate in the synthesis of uric acid. It is elevated in the spinal fluid of patients with Lesch-Nyhan syndrome, a metabolic disorder whose symptoms include cerebral palsy, cognitive deficits, motor dysfunction, self-mutilation, and hyperuricemia. Injection of hypoxanthine (10 μM) increases succinate dehydrogenase and complex II activities and decreases cytochrome c oxidase activity, resulting in neuroenergetic impairment, ATP depletion, and cellular apoptosis in rat striatum. It is also used to induce hyperuricemia in mice for use in the development of hypouricemic agents.

UsesA naturally occurring purine derivative. Pharmaceuticals, Intermediates & Fine Chemicals

UsesHypoxanthine is a nutrient additive for a variety of cell culture applications involving bacterial, parasite (Plasmodium falciparum) and animal cells. Hypoxanthine is a component of selection media used in hybridoma technologies.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
pka
8.7 · 8.7(at 25℃)
color
Colorless to yellow to brown, darken on storage with no loss of purity
Odor
Odorless
biological source
synthetic (organic)
Water Solubility
practically insoluble
Specific Heat Capacity
0.99 J/ · Cp(crystal): 0.99 J/(g·K), at 25℃
Merck
14 · 14,4869
BRN
5811 · 5811
InChI
1S/C5H4N4O/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)
InChIKey
FDGQSTZJBFJUBT-UHFFFAOYSA-N
SMILES
O=C1NC=Nc2nc[nH]c12
LogP
-0.91 · -0.910 (est)
CAS DataBase Reference
68 · 68-94-0(CAS DataBase Reference)
EWG's Food Scores
1 · 1
FDA UNII
2 TN51YD919 · 2TN51YD919
NIST Chemistry Reference
Hypoxanthine(68-94-0)
EPA Substance Registry System
Hypoxanthine (68-94-0)
UNSPSC Code
41116107 · 41116107
NACRES
75 · NA.75
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P264b-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362+P364-P403+P233-P501c
PPE
95 · Eyeshields, Gloves, type N95 (US)
Hazard Codes
Xn
Risk Statements
36 · 36/37/38-22-40
Safety Statements
22 · 22-24/25-37/39-26-36
WGK Germany
3 · 3
RTECS
791000 · UP0791000
Hazard Note
Harmful
TSCA
TSCA listed
HS Code
29335990 · 29335990
Storage Class
11 · 11 - Combustible Solids
Toxicity
50 intraperitoneal · LD50 intraperitoneal in mouse: 750mg/kg
REACH Registrations
Active
No indication of carcinogenicity to humans (not listed by IARC).

Safety data

PPE
Eyeshields, Gloves, type N95 (US)
wgk
3
tsca
TSCA listed
rtecs
UP0791000
hs_code
29335990
Toxicity
LD50 intraperitoneal in mouse: 750mg/kg
risk_code
36/37/38-22-40
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn
hazard_note
Harmful
safety_code
22-24/25-37/39-26-36
Storage Class
11 - Combustible Solids
Hazard statements
H302-H315-H319-H335
REACH Registrations
Active
Precautionary statements
P261-P264b-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362+P364-P403+P233-P501c

UsesHypoxanthine, is used as a marker for energy perturbation in hypoxia/ ischemia. The compound has been used in studies as in indicator, along with uric acid and allantoin , of in vivo free radical reactions. It has been also used in DNA studies to investigate the destabilizing effect it has on DNA duplexes containing hypoxanthine as a base, in a gas phase versus a liquid phase. Hypoxanthine has also been used in studies along with 8-oxoguanine nucleotides to investigate their interaction with human DNA pol (DNA polymerase alpha) and DNA polymerase I from Bacillus stearothermophilus. It is also used as a pharmaceutical intermediate.

General DescriptionHypoxanthine (6-hydroxypurine), a purine derivative is a naturally occurring compound. It is the deaminated form of adenine and a breakdown product of adenosine monophosphate (AMP).

Upstream & downstream products

Upstream raw materials

Sodium ethoxide6-AminothiouracilEthyl cyanoacetateThiourea

Downstream products

6-Dimethylaminopurine6-n-HeptylmercaptopurineAdenine6-Mercaptopurine6-n-Hexylaminopurine6-Ethoxypurine6-Cyanopurine6-benzylaminopurine6-EthylmercaptopurineAcyclovir6-BromopurineN6-Cyclohexyladenosine6-Mercaptopurine monohydrateN-(2-Hydroxyethyl)adenosine6-n-ButoxypurinePurine6-Benzylaminopurine6-Iodopurine6-benzylaminopurine hydrochloride

Additional notes

DefinitionChEBI: A purine nucleobase that consists of purine bearing an oxo substituent at position 6.